Sath Shukla

Companies

• Spero Therapeutics, Inc.Chief executive officer Aug 3, 2023 to now¹
• Spero Therapeutics, Inc.President Aug 3, 2023 to now¹
• Spero Therapeutics, Inc.Board member Aug 3, 2023 to Feb 5, 2024¹
• Spero Therapeutics, Inc.Chief financial officer Jan 5, 2021 to Feb 3, 2023²
• ZIOPHARM OncologyChief financial officer Jul 24, 2019 to Jan 31, 2020³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• STSpero Therapeutics, Inc. SPRO1,736,883 shares⁴$2.0M at $1.14Feb 5, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 5, 2025Sold 106,408 shares at $0.78 of Spero Therapeutics, Inc.⁴
• Feb 5, 2025Sold 42,786 shares at $0.78 of Spero Therapeutics, Inc.⁴
• Feb 5, 2025Sold 6,139 shares at $0.78 of Spero Therapeutics, Inc.⁴
• Feb 3, 2025Granted 751,407 shares of Spero Therapeutics, Inc.⁴
• Aug 27, 2024Sold 2,757 shares at $1.35 of Spero Therapeutics, Inc.⁵
• Aug 5, 2024Sold 17,641 shares at $1.31 of Spero Therapeutics, Inc.⁶
• Aug 2, 2024Sold 14,800 shares at $1.32 of Spero Therapeutics, Inc.⁶
• Feb 5, 2024Sold 45,093 shares at $1.45 of Spero Therapeutics, Inc.⁷
• Feb 2, 2024Sold 30,901 shares at $1.37 of Spero Therapeutics, Inc.⁷
• Feb 1, 2024Granted 679,501 shares of Spero Therapeutics, Inc.⁷
• Aug 29, 2023Sold 4,163 shares at $1.30 of Spero Therapeutics, Inc.⁸
• Aug 28, 2023Sold 1,854 shares at $1.26 of Spero Therapeutics, Inc.⁸
• Aug 1, 2023Granted 266,000 shares of Spero Therapeutics, Inc.⁹
• Feb 2, 2023Sold 9,504 shares at $1.83 of Spero Therapeutics, Inc.¹⁰
• Feb 1, 2023Granted 265,957 shares of Spero Therapeutics, Inc.¹⁰
• Aug 29, 2022Sold 6,017 shares at $0.89 of Spero Therapeutics, Inc.¹¹
• Feb 1, 2022Granted 38,014 shares of Spero Therapeutics, Inc.¹²